>

Vertex Price to Earning Trend from 2010 to 2020

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>VRT</div>
VRTX -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Vertex Pharmaceuticals Income Tax Expense is fairly stable at the moment as compared to the last year. Vertex Pharmaceuticals reported Income Tax Expense of 15 Million in 2019. Check Vertex Pharmaceuticals fundamental indicators over time to gain insight into the future company performance. Apply historical fundamental analysis to find patterns among financial statement drivers such as Direct Expenses of 591 M, Cost of Revenue of 204.4 M or Gross Profit of 1.2 B, as well as many exotic indicators such as Interest Coverage of 18.07, Long Term Debt to Equity of 0.0908 or Calculated Tax Rate of 16.87. This can be a perfect complement to check Vertex Pharmaceuticals Valuation or Volatility. It can also complement various Vertex Pharmaceuticals Technical models. Also please take a look at the analysis of Vertex Pharmaceuticals Correlation with competitors.
Equity
Refresh

Vertex Price to Earning Marginal Breakdown

Showing smoothed Price to Earnings Ratio of Vertex Pharmaceuticals Incorpor with missing and latest data points interpolated. An alternative to [pe] representing the ratio between adjusted share price and earnings per basic share usd.
View

26.41 

          10 Years Trend
 Price to Earnings Ratio 
    
  Timeline 

Vertex Price to Earning Regression Statistics

Arithmetic Mean(58.39)
Coefficient Of Variation(205.47)
Mean Deviation 83.00
Median(54.47)
Standard Deviation 119.97
Sample Variance 14,393
Range 421.39
R-Value(0.51)
Mean Square Error 11,903
R-Squared 0.26
Significance 0.11
Slope(18.29)
Total Sum of Squares 143,926

Vertex Price to Earning Over Time

2016 (160.15) 
2019 (184.17) 
2020  26.41 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Vertex Pharmaceuticals Fundamental Drivers

Vertex Pharmaceuticals Incorpor Fundamental Market Drivers

Short Percent Of Float1.36%
Forward Price Earnings24.23
Shares Short Prior Month3.59M
Average Daily Volume Last 10 Day1.61M
Average Daily Volume In Three Month1.37M
Date Short InterestJanuary 31, 2020
Fifty Day Average232.26
Two Hundred Day Average201.98

Vertex Pharmaceuticals Upcoming Events

Vertex Pharmaceuticals Upcoming Company Events

Upcoming Quarterly Earning ReportMay 5, 2020
Next Earnings ReportJuly 29, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 4, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019
Also please take a look at the analysis of Vertex Pharmaceuticals Correlation with competitors. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.